The realm of biotechnology is constantly evolving, and at the forefront of this revolution stands innovative peptide synthesis. These tiny protein fragments hold immense opportunity for revolutionizing healthcare. Medical Professionals are exploiting the power of engineered peptides to design nov

Viking Therapeutics has formed a mutually beneficial alliance with U.S. biopharmaceutical companies to develop and manufacture its GLP-1 drug candidate, VK2735. This marks a significant advancement in securing dependable production capabilities for these vital therapeutic agents. The agreement en